Alyssa Vanderbeek

Product Manager at Previous career statistical researcher in clinical trial design and analysis. All views my own. She/her.

[Christina Yap @ChristinaBYap]

Exciting fully-funded PhD opportunity @ICR_London in methods research in early phase clinical trials, starting from October 2024. The successful candidate will join an amazing @MRCTMRPDTP community of methodologists and innovators! Please share! https://t.co/ahQsoPyjFe @ICR_CTSU

[Alyssa Vanderbeek @VanderbeekAM]

Google Docs including suggestions in its word count feature has to be universally unacceptable. Right?

[Alyssa Vanderbeek @VanderbeekAM]

Could... could it be that we're one step closer to the dream of using NLP to scrape protocols? https://t.co/ptgTKl5Wtx

[Alyssa Vanderbeek @VanderbeekAM]

I’ll be at Unlearn AI’s booth at #JSM2022 from 10:30-2 today. Stop by to chat and learn more about our mission and current opportunities! Or be sure to visit my colleagues tmrw and Wednesday 9-5 https://t.co/mtHb5r2EPz

[Unlearn.AI @UnlearnAI]

Join us at JSM 2022, 08/06-08/11 in Washington, DC. As an event sponsor, take a photo at the photobooth and visit the Unlearn team at booth #209. @amstatnews

[Alyssa Vanderbeek @VanderbeekAM]

Come be my Director and oversee the cool methodologies we’re working on! Hiring for other roles in research and applied biostats, machine learning, and others

[Unlearn.AI @UnlearnAI]

Unlearn is hiring for a Head of Biostatistics Research and will be reviewing applications and scheduling interviews during JSM 2022. All registered applicants can apply through the JSM Career Portal, here: https://t.co/5W19JdlhnY @Amstatnews

[Kate Manne @kate_manne]

Welcome to America, where we care so much about life that the guns of boys and men proliferate while girls, women, and other pregnant people routinely die for lack of access to abortion

[Alyssa Vanderbeek @VanderbeekAM]

Having #SCT2022 FOMO 😭

[Frank Vinluan @frankvinluan]

You don’t often hear about companies seeking more regulatory oversight. The technology used in clinical trials doesn’t need regulatory approval. #Startup @UnlearnAI sought a review of its #AI tech anyway, and it’s now reaping rewards from the result... https://t.co/75Bo3KefgM

[Unlearn.AI @UnlearnAI]

Unlearn is excited to announce that we have closed a $50 million Series B funding round, led by @insightpartners with participation from new investor @radicalvcfund and existing investors @8VC, @DCVC, @DCVCBio, and @Mubadala. #machinelearning https://t.co/9TcZCBFzMU

[Alyssa Vanderbeek @VanderbeekAM]

My first publication (2018) has surpassed 50 citations! This was an exciting systematic review, where I also derived a procedure to estimate the % of patients enrolled in #Glioblastoma trials https://t.co/G8kRBvrFVU

[Alyssa Vanderbeek @VanderbeekAM]

When there are 10 cores on the new MacBook 16 inch

[Alyssa Vanderbeek @VanderbeekAM]

@Gopal_Kot Absolutely!!

[Alyssa Vanderbeek @VanderbeekAM]

FDA released their final guidance document for master protocols in oncology today. “Platform trial” remains in-explicitly defined — I’m curious about responses to this in academia https://t.co/0mbLdLIE6d

[Christina Yap @ChristinaBYap]

Surge in use of efficient platform trial design in #COVID19 #clinicaltrials (far exceeding historical use), with many adding new treatment arms rapidly.

Joint work @VanderbeekAM @JudithBliss15 and Z.Yin @ICR_CTSU

https://t.co/bAuft9D4bZ

[Alyssa Vanderbeek @VanderbeekAM]

@EpiEllie NYC in March-May 2020 was actually pretty bad as far as US goes. Businesses closed, nothing on the shelves, stay-at-home orders, subway shut-downs, USNS Comfort assistance. With huge population density. For anyone without a car, there wasn't really a way out. Very apocalyptic

[Unlearn.AI @UnlearnAI]

New Employee Spotlight: Meet @UnlearnAI's Research Biostatistician, @VanderbeekAM! Alyssa is an accomplished biostatistician who will be developing new methods for utilizing #DigitalTwins in clinical trial design. #AI #Hiring #WeAreHiring https://t.co/Ao8v2ezQaZ

[Alyssa Vanderbeek @VanderbeekAM]

We're live! https://t.co/mJAyBTjfKj

[Alyssa Vanderbeek @VanderbeekAM]

Happy to announce that my latest work, “Implementation of platform trials in the COVID-19 pandemic: a rapid review”, has been accepted for publication in Contemporary Clinical Trials. (To be shared when available!) 1/6

[Alyssa Vanderbeek @VanderbeekAM]

@ZFusfeld One of my cats LOVES cat springs. Great for independent play https://t.co/xGGhTye7lV